Literature DB >> 28286554

Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?

Nicolas Williet1, Xavier Roblin2.   

Abstract

Entities:  

Year:  2016        PMID: 28286554      PMCID: PMC5330604          DOI: 10.1177/1756283X16670074

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  33 in total

1.  Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.

Authors:  J Bo; H Schrøder; J Kristinsson; B Madsen; C Szumlanski; R Weinshilboum; J B Andersen; K Schmiegelow
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

2.  NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.

Authors:  Y Kakuta; T Naito; M Onodera; M Kuroha; T Kimura; H Shiga; K Endo; K Negoro; Y Kinouchi; T Shimosegawa
Journal:  Pharmacogenomics J       Date:  2015-06-16       Impact factor: 3.550

Review 3.  Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review.

Authors:  Ronald A Booth; Mohammed T Ansari; Evelin Loit; Andrea C Tricco; Laura Weeks; Steve Doucette; Becky Skidmore; Margaret Sears; Richmond Sy; Jacob Karsh
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

4.  6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease.

Authors:  Markus F Neurath; Ralf Kiesslich; Ute Teichgräber; Christine Fischer; Ute Hofmann; Michel Eichelbaum; Peter R Galle; Matthias Schwab
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

5.  Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.

Authors:  Carmen Cuffari; Themistocles Dassopoulos; Lisa Turnbough; Richard E Thompson; Theodore M Bayless
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382

6.  6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

Authors:  Max Reinshagen; Ekkehard Schütz; Victor W Armstrong; Christoph Behrens; Christian von Tirpitz; Andreas Stallmach; Hans Herfarth; Jürgen Stein; Peter Bias; Guido Adler; Maria Shipkova; Wolfgang Kruis; Michael Oellerich; Nicolas von Ahsen
Journal:  Clin Chem       Date:  2007-05-10       Impact factor: 8.327

7.  Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Authors:  T Dassopoulos; M C Dubinsky; J L Bentsen; C F Martin; J A Galanko; E G Seidman; R S Sandler; S B Hanauer
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

8.  NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.

Authors:  Ayumi Asada; Atsushi Nishida; Makoto Shioya; Hirotsugu Imaeda; Osamu Inatomi; Shigeki Bamba; Katsuyuki Kito; Mitsushige Sugimoto; Akira Andoh
Journal:  J Gastroenterol       Date:  2015-11-21       Impact factor: 7.527

9.  Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.

Authors:  U Hindorf; M Lindqvist; C Peterson; P Söderkvist; M Ström; H Hjortswang; A Pousette; S Almer
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

10.  Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Authors:  Kjeld Schmiegelow; Ibrahim Al-Modhwahi; Mette Klarskov Andersen; Mikael Behrendtz; Erik Forestier; Henrik Hasle; Mats Heyman; Jon Kristinsson; Jacob Nersting; Randi Nygaard; Anne Louise Svendsen; Kim Vettenranta; Richard Weinshilboum
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

View more
  2 in total

Review 1.  De-escalation of Therapy in Inflammatory Bowel Disease.

Authors:  Catarina Frias Gomes; Jean-Frédéric Colombel; Joana Torres
Journal:  Curr Gastroenterol Rep       Date:  2018-07-02

2.  Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study.

Authors:  Xiaoxian Qian; Tianrong Wang; Jun Shen; Zhihua Ran
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.